Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans

Journal of Periodontology

Volumn 75, Issue 10, 2004, Pages 1309-1318

  Gurinsky, Brian S ^a   Mills, Michael P ^a   Mellonig, James T ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Bone; Clinical trials; Comparison studies; Demineralized; Enamel matrix derivative; Freeze dried; Grafts; Periodontal regeneration

Indexed keywords

ENAMEL PROTEIN;

ADULT; AGED; ARTICLE; BONE ALLOGRAFT; BONE DEFECT; BONE DEMINERALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENAMEL; FEMALE; FREEZE DRYING; GINGIVA DISEASE; HEALING; HUMAN; MALE; PARALLEL DESIGN; PERIODONTAL DISEASE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

ADULT; AGED; ALVEOLAR BONE LOSS; ALVEOLAR PROCESS; BONE RESORPTION; BONE TRANSPLANTATION; DECALCIFICATION TECHNIQUE; DENTAL ENAMEL PROTEINS; FEMALE; FOLLOW-UP STUDIES; FREEZE DRYING; GINGIVAL RECESSION; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; OSTEOGENESIS; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; SINGLE-BLIND METHOD; TISSUE PRESERVATION; WOUND HEALING;

EID: 8744288670     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.10.1309     Document Type: Article

References (52)

1. American Academy of Periodontology. Glossary of Periodontal Terms, 4th ed. Chicago: American Academy of Periodontology; 2001:44.
2. Froum SJ, Thaler R, Scoop IW, Stahl SS. Osseous autografts. I. Clinical responses to bone blend or hip marrow grafts. J Periodontol 1975;46:515-521.
3. Mellonig JT, GM Bowers, Bright RW, Lawrence JJ. Clinical evaluation of freeze-dried bone allografts in periodontal osseous defects. J Periodontol 1976;47: 125-131.
4. Sanders JJ, Sepe WW, Bowers GM, et al. Clinical evaluation of freeze-dried bone allografts in periodontal osseous defects. Part III. Composite freeze-dried bone allografts with and without autogenous bone grafts. J Periodontol 1983;54:1-8.
5. Rummelhart JM, Mellonig JT, Gray JL, Towle HJ. A comparison of freeze-dried bone allograft in human periodontal osseous defects. J Periodontol 1989;60: 655-663.
6. Bowers GM, Chadroff B, Carnevale R, et al. Histologic evaluation of new attachment apparatus formation in humans, Part II. J Periodontol 1989;60:675-682.
7. Mellonig JT. Autogenous and allogeneic bone grafts in periodontal therapy. Crit Rev Oral Biol Med 1992;3: 333-352.
8. Lovelace TB, Mellonig JT, Meffert RM, Jones AA, Nummikoski PV, Cochran DL. Clinical evaluation of bioactive glass in the treatment of periodontal osseous defects in humans. J Periodontol 1998;69:1027-1035.
9. Schallhorn RG Long-term evaluation of osseous grafts in periodontal therapy. Int Dent J 1980;30:101-116.
10. Froum SJ, Weinberg MA, Rosenberg E, Tarnow D. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: A 12 month re-entry study. J Periodontol 2001;72:25-34.
11. Garrett S. Periodontal regeneration around natural teeth. Ann Periodontol 1996;1:621-666.
12. Mellonig JT. Decalcified freeze-dried bone allograft as an implant material in human periodontal defects. Int J Periodontics Restorative Dent 1984;4(6):40-55.
13. Mellonig JT, Bowers GM, Cotton WR. Comparison of bone graft materials. Part I. New bone formation with autografts and allografts determined by strontium-85. J Periodontol 1981;52:291-296.
14. Mellonig JT, Bowers GM, Bailey RC. Comparison of bone graft materials. Part II. A histological evaluation. J Periodontol 1981;52:297-302.
15. Bowers GM, Chadroff B, Carnevale R. Histologic evaluation of new attachment apparatus formation in humans: Part I. J Periodontol 1989;60:664-674.
16. Bowers GM, Chadroff B, Carnevale R. Histologic evaluation of new attachment apparatus formation in humans: Part III. J Periodontol 1989;60:683-693.
17. Urist MR. Bone: Formation by autoinduction. Science 1965;150:893-899.
18. Schwartz Z, Mellonig JT, Carnes DL, et al. Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation. J Periodontol 1996;67:918-926.
19. Shigeyama YA, D'Errico J, Stone R, Somerman MJ. Commerically-prepared allograft material has biological activity in vitro. J Periodontol 1995;66:478-487.
20. Schwartz Z, Sommers A, Mellonig JT. Addition of human recombinant bone morphogenetic protein-2 to inactive commercial human demineralized freeze-dried bone allograft makes an effective composite bone inductive implant material. J Periodontol 1998;69:1337-1345.
21. Hammarstrom L. Enamel matrix and cementum development, repair and regeneration. J Clin Periodontol 1997; 24:658-668.
22. Brookes SJ, Robinson C, Kirkham J, Bonass WA. Biochemistry and molecular biology of amelogenin proteins of developing dental enamel. Arch Oral Biol 1995;40:1-14.
23. Lyngstadaas SP, Lundberg E, Ekadahl H, Andersson C, Gestrelius S. Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative. J Clin Periodontol 2001;28:181-188.
24. Gestrelius S, Andersson C, Lidstrom D, Hammarstrom L, Somerman M. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol 1997;24:685-692.
25. Heijl L, Heden G, Svardstrom G, Ostgren A. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997;24: 705-714.
26. Zetterstrom O, Andersson C, Erikson L, et al. Clinical safety of enamel matrix derivative (EMDOGAIN) in the treatment of periodontal defects. J Clin Periodontol 1997; 24:697-704.
27. Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol 2001;28:397-403.
28. Yukna RA, Mellonig JT. Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol 2000;71:752-759.
29. Boyan BD, Weesner T, Lohmann CH, et al. Porcine fetal enamel matrix derivative enhances bone formation induced by demineralized freeze-dried bone allograft in vivo. J Periodontol 2000;71:1278-1286.
30. O'Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontol 1972;43:38.
31. Pashley DH. Smear layer: Overview of structure and function. Proc Finn Dent Soc 1992;88:215-224.
32. Blomlof JP, Blomlof LB, Lindskog SF, et al. Smear removal and collagen exposure after non-surgical root planing followed by etching with an EDTA gel preparation. J Periodontol 1996;67:841-845.
33. Cole R. Connective tissue regeneration to periodontally diseased teeth. J Periodontal Res 1980;15:1-9.
34. Register A, Burdick F. Accelerated reattachment with cementogenesis to dentin demineralized in situ. I. Optimum range. J Periodontol 1975;46:302-305.
35. Newman MG, Sanz M, Nachnani S, Saltini C, Anderson L. Effect of 0.12% chlorhexidine on bacterial recolonization following periodontal surgery. J Periodontol 1989;60: 577-581.
36. Golub LM, Ciancio S, Ramamamurthy NS, Leung M, McNamara TF. Low-dose doxycycline therapy: Effect on gingival and crevicular fluid collagenase activity in humans. J Periodontal Res 1990;25:321-330.
37. Rifkin B, Vernillo AT, Golub LM. Blocking periodontal disease progression by inhibiting tissue destructive enzymes: A potential therapeutic role for tetracyclines and their chemically-modified analogs. J Periodontol 1993;64: 819-827.
38. Quintero G, Mellonig JT, Gambill VM, Pelleu GB. A six-month clinical evaluation of decalcified freeze-dried bone allografts in periodontal osseous defects. J Periodontol 1982;53:726-730.
39. Okuda K, Momose M, Miyazaki A. Enamel matrix derivative in the treatment of human intrabony osseous defects. J Periodontol 2000;71:1821-1828.
40. Eger T, Müller P. Periodontal regeneration in vertical bone defects with re-absorbable membranes and enamel matrix proteins. A comparative clinical study. J Ger Dent 1998;9:590-594.
41. Sculean A, Donos N, Windisch P, et al. Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 1999;34:310-322.
42. Sculean A, Donos N, Blaes A, Lauerman M, Reich E, Brecx M. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects-a split-mouth study. J Periodontol 1999;70:255-262.
43. Silvestri M, Ricci G, Rasperini G, Sartori S, Cattaneo V. Comparison of treatments of intrabony defects with enamel matrix derivative, guided tissue regeneration with a nonresorbable membrane and Widman modified flap, a pilot study. J Clin Periodontol 2000;27: 603-610.
44. Tonetti MS, Lang NP, Cortellini P, et al. Enamel matrix proteins in the regenerative therapy of deep intrabony defects: A multicenter randomized controlled clinical trial. J Clin Periodontol 2002;29:317-325.
45. Windisch P, Sculean A, Klein F. Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects. J Periodontol 2002;73:409-417.
46. Pontoriero R, Wennström J, Lindhe J. The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical trial. J Clin Periodontol 1999;26:833-840.
47. Yukna RA, Callan DP, Krauser JT, et al. Multi-center clinical evaluation of combination anorganic bovine derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-month results. J Periodontol 1998;69:655-663.
48. Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M. Multi-center clinical comparison of combination anorganic bovine-derived hydroxyapatitie matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects. 6-month results. J Periodontol 2000;71:1671-1679.
49. Scheyer ET, Velasquez-Plata D, Brunsvold MA, Lasho DJ, Mellonig JT. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans. J Periodontol 2002;73:423-429.
50. Sculean A, Chiantela GC, Windisch P, Gera I, Reich E. Clinical evaluation of an enamel matrix protein derivative (Emdogain) combined with a bovine-derived xenograft (Bio-Oss) for the treatment of intrabony periodontal defects in humans. Int J Periodontics Restorative Dent 2002;22: 259-267.
51. Lekovic V, Camargo PM, Weinlander M, Nedie M, Aleksic Z, Kenney EB. A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Periodontol 2000;71:1110-1116.
52. Velasquez-Plata D, Scheyer ET, Mellonig JT. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Periodontol 2002;73:433-440.